论文部分内容阅读
据有关部门的统计,到2005年全世界治疗哮喘病的新药市场将较1996年增长一倍,达40亿美元。欧洲的哮喘病新药市场占据全世界市场的40%,而法国对这类药品的需求增长要比其邻国德国等国家更高一些。预计到2005年,法国有可能在欧洲成为这类药品的第一大消费市场。值得提醒人们的是,这一增长并不是因为购药量的增加,而更多的是由于新药品价格更高的缘故。
According to relevant department statistics, by 2005, the new drug market for the treatment of asthma worldwide will double compared to 1996, reaching US$4 billion. Europe’s new market for asthma drugs accounts for 40% of the world market, while France’s demand for such drugs has grown more than its neighboring countries such as Germany. It is expected that by 2005, France may become the largest consumer market for such drugs in Europe. It is worth reminding people that this increase is not due to the increase in drug purchases, but more due to the higher price of new drugs.